Makulae, Papulae und Plaques ≤ 10 % der Hautoberfläche
Makulae, Papulae und Plaques ≥ 10% der Hautoberfläche
Makulae, Papulae und Plaques ≤ 10 % der Hautoberfläche a) Makulae b) Plaques ± Makulae
Makulae, Papulae und Plaques ≥ 10% der Hautoberfläche a) Makulae, b) Plaques ± Makulae
Ein oder mehrere Tumore (≥ 1 cm)
Erythrodermie (≥ 80 % Körperoberfläche)
Palpable Lymphknoten; histologisch kein Anhalt für CTCL (NCILN0-2)
Palpable Lymphknoten; histologisch geringe Infiltrate eines T-Zell Lymphoms (NCILN3)
Regional lymph nodes cannot be assessed
No clinical or pathological lymph node involvement
Involvement of one peripheral node region that drains an area of current or prior skin involvement
Involvement of two or more peripheral node regions or involvement of any lymph node region that does not drain an area of current or prior skin involvement
Involvement of central nodes
IA
1
0
0,1
IB
2
IIA
1-2
IIB
3
0-2
IIIA
4
IIIB
IVA1
1-4
IVA2
IVB
0-3
Beyond the factors used to assign T, N, or M categories, no additional prognostic factors are required for stage grouping.2
The Lugano classification includes no prognostic variable for determination of stage. A separate TNM staging system is used for these lymphomas.
Definition: Extent involvement; solitary, regional, generalized (clinical)
Clinical significance: Therapy consideration, overall survival
Definition: Involvement of draining lymph node, nondraining or central (pathology)
Clinical significance: Overall survival
Definition: Visceral organ (pathology)
Definition: Histologic type, immunophenotype
Clinical significance: Affects choice of therapy and overall survival
The authors have not noted any emerging factors for clinical care.